Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del
Clinical trial NCT02797132 · COMPLETED
Trial details
- NCT number
- NCT02797132
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-09-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.